Hujber, Z., Petővári, G., Szoboszlai, N., Dankó, T., Nagy, N., Kriston, C., . . . Sebestyén, A. (2017). Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells. J Exp Clin Cancer Res.
Citação norma ChicagoHujber, Zoltán, et al. "Rapamycin (mTORC1 Inhibitor) Reduces the Production of Lactate and 2-hydroxyglutarate Oncometabolites in IDH1 Mutant Fibrosarcoma Cells." J Exp Clin Cancer Res 2017.
Citação norma MLAHujber, Zoltán, et al. "Rapamycin (mTORC1 Inhibitor) Reduces the Production of Lactate and 2-hydroxyglutarate Oncometabolites in IDH1 Mutant Fibrosarcoma Cells." J Exp Clin Cancer Res 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.